Showing 1 - 3 results of 3 for search 'Ying Zhao MD', query time: 0.03s Refine Results
  1. 1
    An Externally Validated Nomogram for Predicting the Overall Survival of Patients With Diffuse Large B-Cell Lymphoma Based on Clinical Characteristics and Systemic Inflammatory Markers

    An Externally Validated Nomogram for Predicting the Overall Survival of Patients With Diffuse Large B-Cell Lymphoma Based on Clinical Characteristics and Systemic Inflammatory Mark... by Yajiao Liu MM, Li Sheng MM, Haiying Hua MD, Jingfen Zhou BS, Ying Zhao MD, Bei Wang MD

    Published 2023-08-01
    Get full text
    Article
  2. 2
    Higher Expression of With Lower Expression may be Biomarkers for Risk Stratification of Patients With Cytogenetically Normal Acute Myeloid Leukemia

    Higher Expression of With Lower Expression may be Biomarkers for Risk Stratification of Patients With Cytogenetically Normal Acute Myeloid Leukemia by Cunte Chen MD, Zhuowen Chen MD, Chi Leong Chio MD, Ying Zhao MD, Yongsheng Li MM, Zhipeng Liu MM, Zhenyi Jin MD, Xiuli Wu MD, Wei Wei PhD, Qi Zhao PhD, Yangqiu Li MD

    Published 2021-11-01
    Get full text
    Article
  3. 3
    EGFR Thr790Leu as a Potential Resistance Mechanism to First-Generation EGFR Tyrosine Kinase Inhibitor May Respond to Osimertinib in Patients With Lung Adenocarcinoma

    EGFR Thr790Leu as a Potential Resistance Mechanism to First-Generation EGFR Tyrosine Kinase Inhibitor May Respond to Osimertinib in Patients With Lung Adenocarcinoma by Chan Xiang, PhD, Wei Zhang, PhD, MD, Li-Wen Xiong, MD, Xu-Wei Cai, PhD, MD, Hao-Hua Teng, MD, Rui-Ying Zhao, MD, Zhan-Xian Shang, MD, Han Han-Zhang, PhD, Lu Zhang, PhD, Li Yan, MS, Zhi-Qiu Chen, MS, Yu-Chen Han, PhD, MD

    Published 2021-07-01
    Get full text
    Article

Search Tools: